Stay updated with breaking news from Binish Chudgar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- EVERSANA, the pioneer of next-generation commercial services to the global life sciences industry, and Accord BioPharma, the U.S. specialty...
Myovant Sciences and Accord Healthcare enter into exclusive license agreement to commercialize ORGOVYX
Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to Commercialize ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe - read this article along with other careers information, tips and advice on BioSpace
Comera will develop a differentiated formulation of an Intas product using Comera's innovative proprietary SQore formulation platform
/PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd. focused on development of oncology, immunology, and critical care...